Diego Bagnasco

3.5k total citations
103 papers, 1.8k citations indexed

About

Diego Bagnasco is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Diego Bagnasco has authored 103 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Physiology, 47 papers in Pulmonary and Respiratory Medicine and 31 papers in Immunology and Allergy. Recurrent topics in Diego Bagnasco's work include Asthma and respiratory diseases (81 papers), Respiratory and Cough-Related Research (33 papers) and Allergic Rhinitis and Sensitization (30 papers). Diego Bagnasco is often cited by papers focused on Asthma and respiratory diseases (81 papers), Respiratory and Cough-Related Research (33 papers) and Allergic Rhinitis and Sensitization (30 papers). Diego Bagnasco collaborates with scholars based in Italy, United States and United Kingdom. Diego Bagnasco's co-authors include Giorgio Walter Canonica, Giovanni Passalacqua, Gilda Varricchi, Matteo Ferrando, Enrico Heffler, Marco Caminati, Duy Le Pham, Francesco Menzella, Francesco Borriello and Gianenrico Senna and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and CHEST Journal.

In The Last Decade

Diego Bagnasco

97 papers receiving 1.8k citations

Peers

Diego Bagnasco

PHYSI

PRM

IMMUN

SURGE

Francesca Puggioni Italy

Tara F. Carr United States

Morgan Andersson Sweden

Maria Angela Tosca Italy

Luís Miguel Borrego Portugal

Lydiana Ávila Costa Rica

Young Mok Lee South Korea

Heribert Staudinger United States

Asger Sverrild Denmark

Stefano Del Giacco Italy

Francesca Puggioni Italy

Diego Bagnasco

825 ×0.6

PHYSI

456 ×0.6

PRM

459 ×1.0

254 ×0.6

IMMUN

174 ×0.6

SURGE

Citations per year, relative to Diego Bagnasco Diego Bagnasco (= 1×) peers Francesca Puggioni

Countries citing papers authored by Diego Bagnasco

Since Specialization

Citations

This map shows the geographic impact of Diego Bagnasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Bagnasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Bagnasco more than expected).

Fields of papers citing papers by Diego Bagnasco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego Bagnasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Bagnasco. The network helps show where Diego Bagnasco may publish in the future.

Co-authorship network of co-authors of Diego Bagnasco

This figure shows the co-authorship network connecting the top 25 collaborators of Diego Bagnasco. A scholar is included among the top collaborators of Diego Bagnasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego Bagnasco. Diego Bagnasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galli, Aurelio, et al.. (2025). Are there atypical sites of IgG4 related disease in head and neck region? Personal experience and literature review. European Archives of Oto-Rhino-Laryngology. 282(7). 3395–3404.

Bagnasco, Diego, Luisa Brussino, Stefania Nicola, et al.. (2025). Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab. Journal of Personalized Medicine. 15(2). 43–43.

Bagnasco, Diego, et al.. (2025). Background therapy in severe asthma on monoclonal antibody treatment in real life. Respiratory Medicine. 237. 107944–107944. 1 indexed citations

Caruso, Cristiano, Gabriele Ciasca, Antonio Gasbarrini, et al.. (2024). Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?. Allergy. 79(9). 2414–2422. 4 indexed citations

Latorre, Manuela, Angela Rizzi, Pierluigi Paggiaro, et al.. (2024). Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients. Journal of Asthma. 61(10). 1294–1305. 2 indexed citations

Bagnasco, Diego, Alvise Berti, Giorgio Walter Canonica, et al.. (2024). The Role of IL-5 in Type 2 Inflammatory Diseases. European Medical Journal. 62–72. 2 indexed citations

Canevari, Frank Rikki, Alessia Giorli, Giulia Monti, et al.. (2023). Diagnostic therapeutic assistance pathway (PDTA) of type 2 chronic rhinosinusitis. SHILAP Revista de lepidopterología. 4. 1237131–1237131. 2 indexed citations

Liu, Mark C., Diego Bagnasco, Andrea Matucci, et al.. (2023). Mepolizumab in Patients With Severe Asthma and Comorbidities: 1-Year REALITI-A Analysis. The Journal of Allergy and Clinical Immunology In Practice. 11(12). 3650–3661.e3. 19 indexed citations

Ramirez, Giuseppe A., Marco Ripa, Samuele E. Burastero, et al.. (2023). Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses. Microorganisms. 11(2). 346–346. 22 indexed citations

10.

Caminati, Marco, Alessandro Marcon, Diego Bagnasco, et al.. (2023). Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective. Journal of Clinical Medicine. 12(5). 1836–1836. 6 indexed citations

11.

Bagnasco, Diego, Edoardo Savarino, Mona‐Rita Yacoub, et al.. (2023). Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy. Pharmaceutics. 15(9). 2359–2359. 1 indexed citations

12.

Seccia, Veronica, Maria D’Amato, Giulia Scioscia, et al.. (2022). Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach. Journal of Personalized Medicine. 12(7). 1096–1096. 22 indexed citations

13.

Solidoro, Paolo, Stefania Nicola, Giorgio Walter Canonica, et al.. (2022). Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center. Biomedicines. 10(2). 200–200. 11 indexed citations

14.

Caruso, Cristiano, Stefania Colantuono, Gabriele Ciasca, et al.. (2022). Different aspects of severe asthma in real life: Role of Staphylococcus aureus enterotoxins and correlation to comorbidities and disease severity. Allergy. 78(1). 131–140. 14 indexed citations

15.

Bagnasco, Diego, et al.. (2022). Specific Therapy for T2 Asthma. Journal of Personalized Medicine. 12(4). 593–593. 10 indexed citations

16.

Carobbio, Andrea Luigi Camillo, Alessandro Ioppi, Francesco Missale, et al.. (2021). Application of bioendoscopy filters in endoscopic assessment of sinonasal Schneiderian papillomas. International Forum of Allergy & Rhinology. 11(6). 1025–1028. 1 indexed citations

17.

Menzella, Francesco, Alberto Cavazza, Carla Galeone, et al.. (2019). A case of chronic eosinophilic pneumonia in a patient treated with dupilumab. SHILAP Revista de lepidopterología. 1 indexed citations

18.

Bagnasco, Diego, et al.. (2018). Allergen Immunotherapy: Current State and Ways Forward. Journal of Allergy & Therapy. 9(4). 1–2.

19.

Varricchi, Gilda, Diego Bagnasco, Francesco Borriello, Enrico Heffler, & Giorgio Walter Canonica. (2016). Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders. Current Opinion in Allergy and Clinical Immunology. 16(2). 3 indexed citations

20.

Bagnasco, Diego, Matteo Ferrando, Stefano Bernardi, Giovanni Passalacqua, & Giorgio Walter Canonica. (2016). The path to personalized medicine in asthma. Expert Review of Respiratory Medicine. 10(9). 957–965. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact